Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sunshine Biopharma completes preclinical mechanism of clearance study of lead anticancer product

July 28, 2011

Enrollment complete in phase III trial of perifosine/capecitabine in colorectal cancer

July 28, 2011

Merck KGaA team discloses novel PDK1 inhibitors

July 28, 2011

Sanlugen prepares novel cytarabine prodrugs

July 28, 2011

TM-400 receives FDA orphan drug status

July 27, 2011

TH-302 and bevacizumab enter clinical trial in astrocytoma

July 27, 2011

Hutchison MediPharma patents new HGF receptor inhibitors

July 27, 2011

EMA recommends orphan drug status for 4SC's resminostat

July 26, 2011

Orally active histone deacetylase inhibitor displays potent antitumor activity in vivo

July 26, 2011

New cyclin-dependent kinase 9 inhibitors presented by Vichem Chemie Kutato

July 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...